Cochlear implantation in complete remission in a patient with leukemia.
Patients with leukemia have an increased risk of developing sensorineural hearing loss. This is a retrospective review of a profoundly deafened patient with acute myelogenous leukemia who underwent cochlear implantation. The 26-year-old patient was successfully implanted with a Nucleus cochlear implant in the complete remission after peripheral blood stem cell transplantation. To date, with a follow-up of 1 year, the patient has not experienced any complication and has regained useful open-set speech perception. To our knowledge, this is the first reported case of successful cochlear implantation in a patient deafened by acute myelogenous leukemia.
Takeuchi
Kazuhiko
K
Department of Otorhinolaryngology-Head and Neck Surgery, Mie University Graduate School of Medicine, Mie, Japan. kazuhiko@clin.medic.mie-u.ac.jp
Hattori
Taku
T
Masuda
Sawako
S
Usui
Satoko
S
Oka
Koji
K
Sakaida
Hiroshi
H
Majima
Yuichi
Y
D000328:Adult; D019929:Cochlear Implantation / Q000379:methods*; D005500:Follow-Up Studies; D006319:Hearing Loss, Sensorineural / Q000209:etiology / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000601:surgery; D008297:Male; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods; D012074:Remission Induction / Q000379:methods; D013067:Speech Perception / Q000502:physiology